Human papillomaviruses

IARC Monographs on the Evaluation of Carcinogenic Risks to Humans

Volumn 100 B, Issue , 2011, Pages 261-319

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CAPSID PROTEIN L1; CAPSID PROTEIN L2; CAROTENOID; CYANOCOBALAMIN; E1A PROTEIN; GLYCOPROTEIN E1; GLYCOPROTEIN E2; PROTEIN E5; PROTEIN E6; PROTEIN E7; PROTEIN P16; TOCOPHEROL; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN; WART VIRUS VACCINE;

ANUS CANCER; APOPTOSIS; ARTICLE; BLADDER CANCER; BREAST CANCER; CARCINOGENESIS; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL PROLIFERATION; COLON CANCER; DISEASE TRANSMISSION; DNA DAMAGE; ESOPHAGUS CANCER; GENOMIC INSTABILITY; GEOGRAPHY; HEAD AND NECK CANCER; HEREDITY; HOST RANGE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 26; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN PAPILLOMAVIRUS TYPE 70; HUMAN PAPILLOMAVIRUS TYPE 73; HUMAN PAPILLOMAVIRUS TYPE 82; LARYNX CANCER; LATENT PERIOD; LIFE CYCLE; LUNG CANCER; MOUTH CANCER; NONHUMAN; NOSE CANCER; OROPHARYNX CANCER; OVARY CANCER; PAPILLOMAVIRUS INFECTION; PARANASAL SINUS CANCER; PENIS CANCER; PHYLOGENY; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; RECTUM CANCER; RISK FACTOR; SEROLOGY; SKIN CANCER; TARGET CELL; TAXONOMY; TONSIL CANCER; URETHRA CANCER; UTERINE CERVIX CANCER; VAGINA CANCER; VIRION; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS GENOME; VIRUS MORPHOLOGY; VULVA CANCER; WART VIRUS;

EID: 79960738596     PISSN: 10171606     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (408)

1. Accardi R, Dong W, Smet A et al. (2006). Skin human papillomavirus type 38 alters p53 functions by accumulation of deltaNp73. EMBO Rep, 7: 334-340. doi:10.1038/sj.embor.7400615 PMID:16397624
2. Adami HO, Kuper H, Andersson SO et al. (2003). Prostate cancer risk and serologic evidence of human papilloma virus infection: a population-based case-control study. Cancer Epidemiol Biomarkers Prev, 12: 872-875.PMID:14504197
3. Aguayo F, Castillo A, Koriyama C et al. (2007). Human papillomavirus-16 is integrated in lung carcinomas: a study in Chile. Br J Cancer, 97: 85-91. doi:10.1038/sj.bjc.6603848 PMID:17579626
4. Akil N, Yasmeen A, Kassab A et al. (2008). High-risk human papillomavirus infections in breast cancer in Syrian women and their association with Id-1 expression: a tissue microarray study. Br J Cancer, 99: 404-407. doi:10.1038/sj.bjc.6604503 PMID:18648363
5. Alos L, Moyano S, Nadal A et al. (2009). Human papillomaviruses are identified in a subgroup of sinonasal squamous cell carcinomas with favorable outcome. Cancer, 115: 2701-2709. doi:10.1002/cncr.24309 PMID:19365846
6. Alotaibi L, Provost N, Gagnon S et al. (2006). Diversity of cutaneous human papillomavirus types in individuals with and without skin lesion. J Clin Virol, 36: 133-140.doi:10.1016/j.jcv.2006.02.007 PMID:16678481
7. Amundadottir LT, Thorvaldsson S, Gudbjartsson DF et al. (2004). Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family. PLoS Med, 1: e65 doi:10.1371/journal.pmed.0010065 PMID:15630470
8. Anderson S, Shera K, Ihle J et al. (1997). Telomerase activation in cervical cancer. Am J Pathol, 151: 25-31. PMID:9212727
9. Andersson K, Waterboer T, Kirnbauer R et al. (2008). Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesions. Cancer Epidemiol Biomarkers Prev, 17: 189-195. doi:10.1158/1055-9965.EPI-07-0405 PMID:18199724
10. Andersson S, Mints M, Sällström J, Wilander E (2005). The relative distribution of oncogenic types of human papillomavirus in benign, pre-malignant and malignant cervical biopsies. A study with human papillomavirus deoxyribonucleic acid sequence analysis. Cancer Detect Prev, 29: 37-41. doi:10.1016/j.cdp.2004.11.003 PMID:15734215
11. Andrews E, Seaman WT, Webster-Cyriaque J (2009). Oropharyngeal carcinoma in non-smokers and nondrinkers: a role for HPV. Oral Oncol, 45: 486-491. PMID:19027350
12. Androphy EJ, Hubbert NL, Schiller JT, Lowy DR (1987). Identification of the HPV-16 E6 protein from transformed mouse cells and human cervical carcinoma cell lines. EMBO J, 6: 989-992. PMID:3036495
13. Antinore MJ, Birrer MJ, Patel D et al. (1996). The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP1 family of transcription factors. EMBO J, 15: 1950-1960. PMID:8617242
14. Apple RJ, Becker TM, Wheeler CM, Erlich HA (1995). Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma. J Natl Cancer Inst, 87: 427-436. doi:10.1093/jnci/87.6.427 PMID:7861462
15. Apple RJ, Erlich HA, Klitz W et al. (1994). HLA DR-DQ associations with cervical carcinoma show papillomavirus- type specificity. Nat Genet, 6: 157-162. doi:10.1038/ng0294-157 PMID:8162070
16. Appleby P, Beral V, Berrington de González A et al. International Collaboration of Epidemiological Studies of Cervical Cancer. (2006a). Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer, 118: 1481-1495. doi:10.1002/ijc.21493 PMID:16206285
17. Appleby P, Beral V, Berrington de González A et al. International Collaboration of Epidemiological Studies of Cervical Cancer. (2006b). Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies. Int J Cancer, 119: 1108-1124. doi:10.1002/ijc.21953 PMID:16570271
18. Appleby P, Beral V, Berrington de González A et al. International Collaboration of Epidemiological Studies of Cervical Cancer. (2007). Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet, 370: 1609-1621. doi:10.1016/S0140-6736(07)61684-5 PMID:17993361
19. Arbeit JM, Howley PM, Hanahan D (1996). Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice. Proc Natl Acad Sci U S A, 93: 2930-2935. doi:10.1073/pnas.93.7.2930 PMID:8610145
20. Arbeit JM, Münger K, Howley PM, Hanahan D (1994). Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice. J Virol, 68: 4358-4368. PMID:7515971
21. Archer DF (2004). Neoplasia of the female reproductive tract: effects of hormone therapy. Endocrine, 24: 259-264. doi:10.1385/ENDO:24:3:259 PMID:15542895
22. Ashrafi GH, Haghshenas M, Marchetti B, Campo MS (2006). E5 protein of human papillomavirus 16 downregulates HLA class I and interacts with the heavy chain via its first hydrophobic domain. Int J Cancer, 119: 2105-2112. doi:10.1002/ijc.22089 PMID:16823848
23. Ashrafi GH, Haghshenas MR, Marchetti B et al. (2005). E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I. Int J Cancer, 113: 276-283. doi:10.1002/ijc.20558 PMID:15386416
24. Atalay F, Taskiran C, Taner MZ et al. (2007). Detection of human papillomavirus DNA and genotyping in patients with epithelial ovarian carcinoma. J Obstet Gynaecol Res, 33: 823-828. doi:10.1111/j.1447-0756.2007.00663.x PMID:18001449
25. Ault KAFuture II Study Group. (2007). Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials. Lancet, 369: 1861-1868. doi:10.1016/S0140-6736(07)60852-6 PMID:17544766
26. Backes DM, Kurman RJ, Pimenta JM, Smith JS (2009). Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control, 20: 449-457. doi:10.1007/s10552-008-9276-9 PMID:19082746
27. Bahnassy AA, Zekri AR, Abdallah S et al. (2005). Human papillomavirus infection in Egyptian esophageal carcinoma: correlation with p53, p21, mdm2, C-erbB2 and impact on survival. Pathol Int, 55: 53-62. doi:10.1111/j.1440-1827.2005.01804.x PMID:15693850
28. Balis V, Sourvinos G, Soulitzis N et al. (2007). Prevalence of BK virus and human papillomavirus in human prostate cancer. Int J Biol Markers, 22: 245-251. PMID:18161654
29. Balsitis SJ, Sage J, Duensing S et al. (2003). Recapitulation of the effects of the human papillomavirus type 16 E7 oncogene on mouse epithelium by somatic Rb deletion and detection of pRb-independent effects of E7 in vivo. Mol Cell Biol, 23: 9094-9103. doi:10.1128/MCB.23.24.9094-9103.2003 PMID:14645521
30. Band V, De Caprio JA, Delmolino L et al. (1991). Loss of p53 protein in human papillomavirus type 16 E6-immortalized human mammary epithelial cells. J Virol, 65: 6671-6676. PMID:1658367
31. Banks L, Spence P, Androphy E et al. (1987). Identification of human papillomavirus type 18 E6 polypeptide in cells derived from human cervical carcinomas. J Gen Virol, 68: 1351-1359. doi:10.1099/0022-1317-68-5-1351 PMID:3033140
32. Barbosa MS & Schlegel R (1989). The E6 and E7 genes of HPV-18 are sufficient for inducing two-stage in vitro transformation of human keratinocytes. Oncogene, 4: 1529-1532. PMID:2556677
33. Bardin A, Vaccarella S, Clifford GM et al. (2008). Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland. Eur J Cancer, 44: 557-564. doi:10.1016/j.ejca.2007.12.001 PMID:18191395
34. Barghi MR, Hajimohammadmehdiarbab A, Moghaddam SM, Kazemi B (2005). Correlation between human papillomavirus infection and bladder transitional cell carcinoma. BMC Infect Dis, 5: 102 doi:10.1186/1471-2334-5-102 PMID:16274490
35. Becker TM, Wheeler CM, McGough NS et al. (1994). Sexually transmitted diseases and other risk factors for cervical dysplasia among southwestern Hispanic and non-Hispanic white women. JAMA, 271: 1181-1188. doi:10.1001/jama.271.15.1181 PMID:8151876
36. Bedard KM, Underbrink MP, Howie HL, Galloway DA (2008). The E6 oncoproteins from human betapapillomaviruses differentially activate telomerase through an E6AP-dependent mechanism and prolong the lifespan of primary keratinocytes. J Virol, 82: 3894-3902. doi:10.1128/JVI.01818-07 PMID:18256157
37. Bedell MA, Jones KH, Grossman SR, Laimins LA (1989). Identification of human papillomavirus type 18 transforming genes in immortalized and primary cells. J Virol, 63: 1247-1255. PMID:2536832
38. Beerens E, Van Renterghem L, Praet M et al. (2005). Human papillomavirus DNA detection in women with primary abnormal cytology of the cervix: prevalence and distribution of HPV genotypes. Cytopathology, 16: 199-205. doi:10.1111/j.1365-2303.2005.00266.x PMID:16048506
39. Beral V, Hermon C, Kay C et al. (1999). Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46 000 women from Royal College of General Practitioners' oral contraception study. BMJ, 318: 96-100. PMID:9880284
40. Bergh J, Marklund I, Gustavsson C et al. (2007). No link between viral findings in the prostate and subsequent cancer development. Br J Cancer, 96: 137-139. doi:10.1038/sj.bjc.6603480 PMID:17117176
41. Berrington A, Jha P, Peto J et al. UK National Case-Control Study of Cervical Cancer. (2002). Oral contraceptives and cervical cancer. Lancet, 360: 410 doi:10.1016/S0140-6736(02)09578-8 PMID:12241800
42. Bertelsen BI, Kugarajh K, Skar R, Laerum OD (2006). HPV subtypes in cervical cancer biopsies between 1930 and 2004: detection using general primer pair PCR and sequencing. Virchows Arch, 449: 141-147. doi:10.1007/s00428-006-0232-3 PMID:16767449
43. Bezerra AL, Lopes A, Landman G et al. (2001). Clinicopathologic features and human papillomavirus dna prevalence of warty and squamous cell carcinoma of the penis. Am J Surg Pathol, 25: 673-678. doi:10.1097/00000478-200105000-00017 PMID:11342782
44. Bhatla N, Dar L, Patro AR et al. (2006). Human papillomavirus type distribution in cervical cancer in Delhi, India. Int J Gynecol Pathol, 25: 398-402. doi:10.1097/01.pgp.0000209574.62081.e4 PMID:16990719
45. Bigler LR, Tate Thigpen J, Blessing JA et al. Gynecologic Oncology Group. (2004). Evaluation of tamoxifen in persistent or recurrent nonsquamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Int J Gynecol Cancer, 14: 871-874. doi:10.1111/j.1048-891X.2004.14523.x PMID:15361197
46. Bjørge T, Dillner J, Anttila T et al. (1997). Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers. BMJ, 315: 646-649. PMID:9310566
47. Bjørge T, Engeland A, Luostarinen T et al. (2002). Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study. Br J Cancer, 87: 61-64. doi:10.1038/sj.bjc.6600350 PMID:12085257
48. Blanton RA, Coltrera MD, Gown AM et al. (1992). Expression of the HPV16 E7 gene generates proliferation in stratified squamous cell cultures which is independent of endogenous p53 levels. Cell Growth Differ, 3: 791-802. PMID:1334693
49. Bodaghi S, Yamanegi K, Xiao SY et al. (2005). Colorectal papillomavirus infection in patients with colorectal cancer. Clin Cancer Res, 11: 2862-2867. doi:10.1158/1078-0432.CCR-04-1680 PMID:15837733
50. Bosch FX, Burchell AN, Schiffman M et al. (2008). Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine, 26: Suppl 10 K1-K16. doi:10.1016/j.vaccine.2008.05.064 PMID:18847553
51. Bosch FX, Castellsagué X, Muñoz N et al. (1996). Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain. J Natl Cancer Inst, 88: 1060-1067. doi:10.1093/jnci/88.15.1060 PMID:8683637
52. Bouwes Bavinck JN, Plasmeijer EI, Feltkamp MC (2008). Beta-papillomavirus infection and skin cancer. J Invest Dermatol, 128: 1355-1358. doi:10.1038/jid.2008.123 PMID:18478011
53. Brake T & Lambert PF (2005). Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model. Proc Natl Acad Sci U S A, 102: 2490-2495. doi:10.1073/pnas.0409883102 PMID:15699322
54. Bryan JT, Taddeo F, Skulsky D et al. (2006). Detection of specific human papillomavirus types in paraffinembedded sections of cervical carcinomas. J Med Virol, 78: 117-124. doi:10.1002/jmv.20512 PMID:16299730
55. Bulk S, Berkhof J, Bulkmans NW et al. (2006). Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands. Br J Cancer, 94: 171-175. doi:10.1038/sj.bjc.6602915 PMID:16404371
56. Bulkmans NW, Berkhof J, Rozendaal L et al. (2007). Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet, 370: 1764-1772. doi:10.1016/S0140-6736(07)61450-0 PMID:17919718
57. Bulkmans NW, Bleeker MC, Berkhof J et al. (2005). Prevalence of types 16 and 33 is increased in high-risk human papillomavirus positive women with cervical intraepithelial neoplasia grade 2 or worse. Int J Cancer, 117: 177-181. doi:10.1002/ijc.21210 PMID:15900579
58. Burchell AN, Winer RL de SS, de Sanjosé S, Franco EL (2006). Chapter 6: Epidemiology and transmission dynamics of genital HPV infection. Vaccine, 24: Suppl 3S3, 52-61. doi:10.1016/j.vaccine.2006.05.031 PMID:16950018
59. Butz K, Denk C, Ullmann A et al. (2000). Induction of apoptosis in human papillomaviruspositive cancer cells by peptide aptamers targeting the viral E6 oncoprotein. Proc Natl Acad Sci U S A, 97: 6693-6697. doi:10.1073/pnas.110538897 PMID:10829072
60. Butz K, Ristriani T, Hengstermann A et al. (2003). SiRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells. Oncogene, 22: 5938-5945. doi:10.1038/sj.onc.1206894 PMID:12955072
61. Caldeira S, Zehbe I, Accardi R et al. (2003). The E6 and E7 proteins of the cutaneous human papillomavirus type 38 display transforming properties. J Virol, 77: 2195-2206. doi:10.1128/JVI.77.3.2195-2206.2003 PMID:12525654
62. Cambruzzi E, Zettler CG, Alexandre CO (2005). Expression of Ki-67 and squamous intraepithelial lesions are related with HPV in endocervical adeno-carcinoma. Pathol Oncol Res, 11: 114-120. doi:10.1007/BF02893378 PMID:15999157
63. Cañadas MP, Bosch FX, Junquera ML et al. (2004). Concordance of prevalence of human papillomavirus DNA in anogenital and oral infections in a highrisk population. J Clin Microbiol, 42: 1330-1332. doi:10.1128/JCM.42.3.1330-1332.2004 PMID:15004111
64. Carlson JW, Nucci MR, Brodsky J et al. (2007). Biomarkerassisted diagnosis of ovarian, cervical and pulmonary small cell carcinomas: the role of TTF-1, WT-1 and HPV analysis. Histopathology, 51: 305-312. doi:10.1111/j.1365-2559.2007.02790.x PMID:17727473
65. Carter JJ, Madeleine MM, Shera K et al. (2001). Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites. Cancer Res, 61: 1934-1940. PMID:11280749
66. Casabonne D, Lally A, Mitchell L et al. (2009). A casecontrol study of cutaneous squamous cell carcinoma among Caucasian organ transplant recipients: the role of antibodies against human papillomavirus and other risk factors. Int J Cancer, 125: 1935-1945. doi:10.1002/ijc.24511 PMID:19588489
67. Casabonne D, Michael KM, Waterboer T et al. (2007). A prospective pilot study of antibodies against human papillomaviruses and cutaneous squamous cell carcinoma nested in the Oxford component of the European Prospective Investigation into Cancer and Nutrition. Int J Cancer, 121: 1862-1868. doi:10.1002/ijc.22885 PMID:17565742
68. Castellsagué X, de Sanjosé S, Aguado KS et al. WHO/ICO Information Centre on HPV and Cervical Cancer. (2007). HPV and cervical cancer in the 2007 report. Vaccine, 25: Suppl 3C1-C230. PMID:18068032
69. Castellsagué X, Klaustermeier J, Carrilho C et al. (2008). Vaccine-related HPV genotypes in women with and without cervical cancer in Mozambique: burden and potential for prevention. Int J Cancer, 122: 1901-1904. doi:10.1002/ijc.23292 PMID:18076064
70. Castillo A, Aguayo F, Koriyama C et al. (2006). Human papillomavirus in esophageal squamous cell carcinoma in Colombia and Chile. World J Gastroenterol, 12: 6188-6192. PMID:17036393
71. Castle PE, Hillier SL, Rabe LK et al. (2001). An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epidemiol Biomarkers Prev, 10: 1021-1027. PMID:11588127
72. Castle PE, Schiffman M, Herrero R et al. (2005a). A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis, 191: 1808-1816. doi:10.1086/428779 PMID:15871112
73. Castle PE, Wacholder S, Lorincz AT et al. (2002). A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. J Natl Cancer Inst, 94: 1406-1414. PMID:12237286
74. Castle PE, Walker JL, Schiffman M, Wheeler CM (2005b). Hormonal contraceptive use, pregnancy and parity, and the risk of cervical intraepithelial neoplasia 3 among oncogenic HPV DNA-positive women with equivocal or mildly abnormal cytology. Int J Cancer, 117: 1007-1012. doi:10.1002/ijc.21279 PMID:15986443
75. Cazzaniga M, Gheit T, Casadio C et al. (2009). Analysis of the presence of cutaneous and mucosal papillomavirus types in ductal lavage fluid, milk and colostrums to evaluate its role in breast carcinogenesis. Breast Cancer Res Treat, 114: 599-605. doi:10.1007/s10549-008-0040-3 PMID:18465220
76. Chan PK, Cheung TH, Tam AO et al. (2006). Biases in human papillomavirus genotype prevalence assessment associated with commonly used consensus primers. Int J Cancer, 118: 243-245. doi:10.1002/ijc.21299 PMID:16032705
77. Charfi L, Jouffroy T, de Cremoux P et al. (2008). Two types of squamous cell carcinoma of the palatine tonsil characterized by distinct etiology, molecular features and outcome. Cancer Lett, 260: 72-78. doi:10.1016/j.canlet.2007.10.028 PMID:18060686
78. Chen CA, Liu CY, Chou HH et al. Taiwan Cooperative Oncologic Group. (2006). The distribution and differential risks of human papillomavirus genotypes in cervical preinvasive lesions: A Taiwan Cooperative Oncologic Group Study. Int J Gynecol Cancer, 16: 1801-1808. doi:10.1111/j.1525-1438.2006.00655.x PMID:17009975
79. Cheng S, Schmidt-Grimminger DC, Murant T et al. (1995). Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes Dev, 9: 2335-2349. doi:10.1101/gad.9.19.2335 PMID:7557386
80. Cheng YW, Wu MF, Wang J et al. (2007). Human papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation. Cancer Res, 67: 10686-10693. doi:10.1158/0008-5472.CAN-07-1461 PMID:18006810
81. Chung SH, Wiedmeyer K, Shai A et al. (2008). Requirement for estrogen receptor alpha in a mouse model for human papillomavirus-associated cervical cancer. Cancer Res, 68: 9928-9934. doi:10.1158/0008-5472.CAN-08-2051 PMID:19047174
82. Ciotti M, Paba P, Bonifacio D et al. (2006). Single or multiple HPV types in cervical cancer and associated metastases. Oncol Rep, 15: 143-148. PMID:16328047
83. Clifford G & Franceschi S (2008). Members of the human papillomavirus type 18 family (alpha-7 species) share a common association with adenocarcinoma of the cervix. Int J Cancer, 122: 1684-1685. doi:10.1002/ijc.23282 PMID:18059025
84. Clifford GM, Gallus S, Herrero R et al. IARC HPV Prevalence Surveys Study Group. (2005a). Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet, 366: 991-998. doi:10.1016/S0140-6736(05)67069-9 PMID:16168781
85. Clifford GM, Rana RK, Franceschi S et al. (2005b). Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev, 14: 1157-1164. doi:10.1158/1055-9965.EPI-04-0812 PMID:15894666
86. Clifford GM, Smith JS, Plummer M et al. (2003). Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer, 88: 63-73. doi:10.1038/sj.bjc.6600688 PMID:12556961
87. Coissard CJ, Besson G, Polette MC et al. (2005). Prevalence of human papillomaviruses in lung carcinomas: a study of 218 cases. Mod Pathol, 18: 1606-1609. PMID:16056245
88. Conrad M, Bubb VJ, Schlegel R (1993). The human papillomavirus type 6 and 16 E5 proteins are membrane- associated proteins which associate with the 16-kilodalton pore-forming protein. J Virol, 67: 6170-6178. PMID:7690419
89. Cordano P, Gillan V, Bratlie S et al. (2008). The E6E7 oncoproteins of cutaneous human papillomavirus type 38 interfere with the interferon pathway. Virology, 377: 408-418. doi:10.1016/j.virol.2008.04.036 PMID:18519144
90. Couto E & Hemminki K (2006). Heritable and environmental components in cervical tumors. Int J Cancer, 119: 2699-2701.doi:10.1002/ijc.22226 PMID:16991123
91. Crook T, Storey A, Almond N et al. (1988). Human papillomavirus type 16 cooperates with activated ras and fos oncogenes in the hormone-dependent transformation of primary mouse cells. Proc Natl Acad Sci U S A, 85: 8820-8824. doi:10.1073/pnas.85.23.8820 PMID:2848240
92. Cuzick J, Terry G, Ho L et al. (2000). Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women. Br J Cancer, 82: 1348-1352. PMID:10755413
93. D'Souza G, Kreimer AR, Viscidi R et al. (2007). Casecontrol study of human papillomavirus and oropharyngeal cancer. N Engl J Med, 356: 1944-1956. doi:10.1056/NEJMoa065497 PMID:17494927
94. da Silva CE, da Silva ID, Cerri A, Weckx LL (2007). Prevalence of human papillomavirus in squamous cell carcinoma of the tongue. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 104: 497-500. doi:10.1016/j.tripleo.2007.04.028 PMID:17656122
95. da Silva CS, Adad SJ, Hazarabedian de Souza MA et al. (2004). Increased frequency of bacterial vaginosis and Chlamydia trachomatis in pregnant women with human papillomavirus infection. Gynecol Obstet Invest, 58: 189-193. doi:10.1159/000079822 PMID:15256825
96. Dabić MM, Nola M, Tomicić I et al. (2008). Adenocarcinoma of the uterine cervix: prognostic significance of clinicopathologic parameters, flow cytometry analysis and HPV infection. Acta Obstet Gynecol Scand, 87: 366-372. doi:10.1080/00016340801936560 PMID:18307079
97. Daling JR, Madeleine MM, Johnson LG et al. (2004). Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer, 101: 270-280. doi:10.1002/cncr.20365 PMID:15241823
98. Daling JR, Madeleine MM, Schwartz SM et al. (2002). A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol, 84: 263-270. doi:10.1006/gyno.2001.6502 PMID:11812085
99. Damber JE & Aus G (2008). Prostate cancer. Lancet, 371: 1710-1721. doi:10.1016/S0140-6736(08)60729-1 PMID:18486743
100. Damin DC, Caetano MB, Rosito MA et al. (2007). Evidence for an association of human papillomavirus infection and colorectal cancer. Eur J Surg Oncol, 33: 569-574. doi:10.1016/j.ejso.2007.01.014 PMID:17321098
101. Daponte A, Pournaras S, Mademtzis I et al. (2006). Evaluation of high-risk human papillomavirus types PCR detection in paired urine and cervical samples of women with abnormal cytology. J Clin Virol, 36: 189-193. doi:10.1016/j.jcv.2006.03.009 PMID:16690350
102. De Boer MA, Peters LA, Aziz MF et al. (2005). Human papillomavirus type 18 variants: histopathology and E6/E7 polymorphisms in three countries. Int J Cancer, 114: 422-425 doi:10.1002/ijc.20727 PMID:15551313
103. de Cremoux P, de la Rochefordière A, Savignoni A et al. (2009). Different outcome of invasive cervical cancer associated with high-risk versus intermediate-risk HPV genotype. Int J Cancer, 124: 778-782. doi:10.1002/ijc.24075 PMID:19035459
104. de Oliveira DE, Bacchi MM, Macarenco RSS et al. (2006). Human papillomavirus and Epstein-Barr virus infection, p53 expression, and cellular proliferation in laryngeal carcinoma. Am J Clin Pathol, 126: 284-293. doi:10.1309/UU2JADUEHDWATVM9 PMID:16891205
105. de Sanjosé S, Diaz M, Castellsagué X et al. (2007). Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis, 7: 453-459. doi:10.1016/S1473-3099(07)70158-5 PMID:17597569
106. de Sanjosé S, Muñoz N, Bosch FX et al. (1994). Sexually transmitted agents and cervical neoplasia in Colombia and Spain. Int J Cancer, 56: 358-363. doi:10.1002/ijc.2910560311 PMID:8314322
107. de Villiers EM, Fauquet C, Broker TR et al. (2004). Classification of papillomaviruses. Virology, 324: 17-27. doi:10.1016/j.virol.2004.03.033 PMID:15183049
108. De Vuyst H, Clifford GM, Nascimento MC et al. (2009). Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer, 124: 1626-1636. doi:10.1002/ijc.24116 PMID:19115209
109. De Vuyst H, Gichangi P, Estambale B et al. (2008). Human papillomavirus types in women with invasive cervical carcinoma by HIV status in Kenya. Int J Cancer, 122: 244-246. doi:10.1002/ijc.23045 PMID:17764116
110. Deacon JM, Evans CD, Yule R et al. (2000). Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a casecontrol study nested within the Manchester cohort. Br J Cancer, 83: 1565-1572. doi:10.1054/bjoc.2000.1523 PMID:11076670
111. Del Mistro A, Salamanca HF, Trevisan R et al. (2006). Human papillomavirus typing of invasive cervical cancers in Italy. Infect Agent Cancer, 1: 9 doi:10.1186/1750-9378-1-9 PMID:17192187
112. Dell'Oste V, Azzimonti B, De Andrea M et al. (2009). High beta-HPV DNA loads and strong seroreactivity are present in epidermodysplasia verruciformis. J Invest Dermatol, 129: 1026-1034. doi:10.1038/jid.2008.317 PMID:18923444
113. Dong W, Arpin C, Accardi R et al. (2008). Loss of p53 or p73 in human papillomavirus type 38 E6 and E7 transgenic mice partially restores the UV-activated cell cycle checkpoints. Oncogene, 27: 2923-2928. doi:10.1038/sj.onc.1210944 PMID:18026133
114. Dong W, Kloz U, Accardi R et al. (2005). Skin hyperproliferation and susceptibility to chemical carcinogenesis in transgenic mice expressing E6 and E7 of human papillomavirus type 38. J Virol, 79: 14899-14908. doi:10.1128/JVI.79.23.14899-14908.2005 PMID:16282489
115. Drummond AJ & Rambaut A (2007). BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol, 7: 214 PMID:17996036
116. Duensing S, Duensing A, Flores ER et al. (2001). Centrosome abnormalities and genomic instability by episomal expression of human papillomavirus type 16 in raft cultures of human keratinocytes. J Virol, 75: 7712-7716. doi:10.1128/JVI.75.16.7712-7716.2001 PMID:11462043
117. Duensing S, Duensing A, Lee DC et al. (2004). Cyclindependent kinase inhibitor indirubin-3′-oxime selectively inhibits human papillomavirus type 16 E7-induced numerical centrosome anomalies. Oncogene, 23: 8206-8215. doi:10.1038/sj.onc.1208012 PMID:15378001
118. Duensing S, Lee LY, Duensing A et al. (2000). The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. Proc Natl Acad Sci U S A, 97: 10002-10007. doi:10.1073/pnas.170093297 PMID:10944189
119. Duensing S & Münger K (2002). Human papillomaviruses and centrosome duplication errors: modeling the originsof genomic instability. Oncogene, 21: 6241-6248. doi:10.1038/sj.onc.1205709 PMID:12214255
120. Duensing S & Münger K (2003). Human papillomavirus type 16 E7 oncoprotein can induce abnormal centrosome duplication through a mechanism independent of inactivation of retinoblastoma protein family members. J Virol, 77: 12331-12335. doi:10.1128/JVI.77.22.12331-12335.2003 PMID:14581569
121. Duggan-Keen MF, Keating PJ, Stevens FR et al. (1996). Immunogenetic factors in HPV-associated cervical cancer: influence on disease progression. Eur J Immunogenet, 23: 275-284. doi:10.1111/j.1744-313X.1996.tb00123.x PMID:8858284
122. Dunne EF, Nielson CM, Stone KM et al. (2006). Prevalence of HPV infection among men: A systematic review of the literature. J Infect Dis, 194: 1044-1057. doi:10.1086/507432 PMID:16991079
123. Dürst M, Dzarlieva-Petrusevska RT, Boukamp P et al. (1987). Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene, 1: 251-256. PMID:2838778
124. Dürst M, Gallahan D, Jay G, Rhim JS (1989). Glucocorticoid-enhanced neoplastic transformation of human keratinocytes by human papillomavirus type 16 and an activated ras oncogene. Virology, 173: 767-771. doi:10.1016/0042-6822(89)90595-3 PMID:2556855
125. el-Deiry WS, Tokino T, Velculescu VE et al. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825. doi:10.1016/0092-8674(93)90500-P PMID:8242752
126. El-Mofty SK & Lu DW (2005). Prevalence of high-risk human papillomavirus DNA in nonkeratinizing (cylindrical cell) carcinoma of the sinonasal tract: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol, 29: 1367-1372. doi:10.1097/01.pas.0000173240.63073.fe PMID:16160480
127. Ernster JA, Sciotto CG, O'Brien MM et al. (2007). Rising incidence of oropharyngeal cancer and the role of oncogenic human papilloma virus. Laryngoscope, 117: 2115-2128. doi:10.1097/MLG.0b013e31813e5fbb PMID:17891052
128. Esmaeili M, Bonyadi M, Dastranj A et al. (2008). HPV typing in women with cervical precancerous and cancerous lesions in northwestern Iran. Gynecol Obstet Invest, 66: 68-72. doi:10.1159/000134917 PMID:18500169
129. Fanta BE (2005). The distribution of Human Papilloma Virus infection in women with cervical histological abnormalities from an area with high incidence of cervical cancer. Ethiop Med J, 43: 151-158. PMID:16370546
130. Far AE, Aghakhani A, Hamkar R et al. (2007). Frequency of human papillomavirus infection in oesophageal squamous cell carcinoma in Iranian patients. Scand J Infect Dis, 39: 58-62. doi:10.1080/00365540600740496 PMID:17366014
131. Fausch SC, Da Silva DM, Kast WM (2003). Differential uptake and cross-presentation of human papillomavi- rus virus-like particles by dendritic cells and Langerhans cells. Cancer Res, 63: 3478-3482. PMID:12839929
132. Fei JW & de Villiers EM (2008). Degradation of HPV20E6 by p53: Delta Np63 alpha and mutant p53R248W protect the wild type p53 mediated caspase-degradation. Int J Cancer, 123: 108-116. doi:10.1002/ijc.23506 PMID:18412244
133. Fei Y, Yang J, Hsieh WC et al. (2006). Different human papillomavirus 16/18 infection in Chinese non-small cell lung cancer patients living in Wuhan, China. Jpn J Clin Oncol, 36: 274-279. doi:10.1093/jjco/hyl017 PMID:16690730
134. Feltkamp MC, Broer R, di Summa FM et al. (2003). Seroreactivity to epidermodysplasia verruciformisrelated human papillomavirus types is associated with nonmelanoma skin cancer. Cancer Res, 63: 2695-2700. PMID:12750299
135. Feltkamp MC, de Koning MN, Bavinck JN, Ter Schegget J (2008). Betapapillomaviruses: innocent bystanders or causes of skin cancer. J Clin Virol, 43: 353-360. doi:10.1016/j.jcv.2008.09.009 PMID:18986829
136. Ferreira M, Crespo M, Martins L, Félix A (2008). HPV DNA detection and genotyping in 21 cases of primary invasive squamous cell carcinoma of the vagina. Mod Pathol, 21: 968-972. doi:10.1038/modpathol.2008.91 PMID:18500261
137. Filippova M, Parkhurst L, Duerksen-Hughes PJ (2004). The human papillomavirus 16 E6 protein binds to Fasassociated death domain and protects cells from Fastriggered apoptosis. J Biol Chem, 279: 25729-25744. doi:10.1074/jbc.M401172200 PMID:15073179
138. Filippova M, Song H, Connolly JL et al. (2002). The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis. J Biol Chem, 277: 21730-21739. doi:10.1074/jbc.M200113200 PMID:11934887
139. Forslund O (2007). Genetic diversity of cutaneous human papillomaviruses. J Gen Virol, 88: 2662-2669. doi:10.1099/vir.0.82911-0 PMID:17872517
140. Forslund O, Iftner T, Andersson K et al. Viraskin Study Group. (2007). Cutaneous human papillomaviruses found in sun-exposed skin: Beta-papillomavirus species 2 predominates in squamous cell carcinoma. J Infect Dis, 196: 876-883. doi:10.1086/521031 PMID:17703418
141. Foster SA, Demers GW, Etscheid BG, Galloway DA (1994). The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest. J Virol, 68: 5698-5705. PMID:8057451
142. Franceschi S, Herrero R, Clifford GM et al. (2006). Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer, 119: 2677-2684. doi:10.1002/ijc.22241 PMID:16991121
143. Frisch M, Fenger C, van den Brule AJ et al. (1999). Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses. Cancer Res, 59: 753-757. PMID:9973228
144. Frisch M, Glimelius B, van den Brule AJ et al. (1997). Sexually transmitted infection as a cause of anal cancer. N Engl J Med, 337: 1350-1358. doi:10.1056/NEJM199711063371904 PMID:9358129
145. Funk JO, Waga S, Harry JB et al. (1997). Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7oncoprotein. Genes Dev, 11: 2090-2100. doi:10.1101/gad.11.16.2090 PMID:9284048
146. Gargiulo F, De Francesco MA, Schreiber C et al. (2007). Prevalence and distribution of single and multiple HPV infections in cytologically abnormal cervical samples from Italian women. Virus Res, 125: 176-182. doi:10.1016/j.virusres.2006.12.017 PMID:17257705
147. Garland SM, Hernandez-Avila M, Wheeler CM et al. Females United to Unilaterally Reduce Endo/Ectocervical Disease (FUTURE) I Investigators. (2007). Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med, 356: 1928-1943. doi:10.1056/NEJMoa061760 PMID:17494926
148. Genther Williams SM, Disbrow GL, Schlegel R et al. (2005). Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogene. Cancer Res, 65: 6534-6542. doi:10.1158/0008-5472.CAN-05-0083 PMID:16061632
149. Georgopoulos NT, Proffitt JL, Blair GE (2000). Transcriptional regulation of the major histocompatibility complex (MHC) class I heavy chain, TAP1 and LMP2 genes by the human papillomavirus (HPV) type 6b, 16 and 18 E7 oncoproteins. Oncogene, 19: 4930-4935. doi:10.1038/sj.onc.1203860 PMID:11039910
150. Ghaffari SR, Sabokbar T, Mollahajian H et al. (2006). Prevalence of human papillomavirus genotypes in women with normal and abnormal cervical cytology in Iran. Asian Pac J Cancer Prev, 7: 529-532. PMID:17250423
151. Gheit T, Vaccarella S, Schmitt M et al. (2009). Prevalence of human papillomavirus types in cervical and oral cancers in central India. Vaccine, 27: 636-639. doi:10.1016/j.vaccine.2008.11.041 PMID:19056450
152. Giordano G, D'Adda T, Gnetti L et al. (2008). Role of human papillomavirus in the development of epithelial ovarian neoplasms in Italian women. J Obstet Gynaecol Res, 34: 210-217. doi:10.1111/j.1447-0756.2008.00759.x PMID:18412784
153. Giuliano AR, Papenfuss M, Abrahamsen M et al. (2001). Human papillomavirus infection at the United States- Mexico border: implications for cervical cancer prevention and control. Cancer Epidemiol Biomarkers Prev, 10: 1129-1136. PMID:11700260
154. Giuliano AR, Papenfuss M, De Galaz EM et al. (2004). Risk factors for squamous intraepithelial lesions (SIL) of the cervix among women residing at the US-Mexico border. Int J Cancer, 109: 112-118. doi:10.1002/ijc.11656 PMID:14735476
155. Giuliano AR, Papenfuss M, Nour M et al. (1997). Antioxidant nutrients: associations with persistent human papillomavirus infection. Cancer Epidemiol Biomarkers Prev, 6: 917-923. PMID:9367065
156. Giuliano AR, Siegel EM, Roe DJ et al. Ludwig-McGill HPV Natural History Study. (2003). Dietary intake and risk of persistent human papillomavirus (HPV) infection: the Ludwig-McGill HPV Natural History Study. J Infect Dis, 188: 1508-1516. doi:10.1086/379197 PMID:14624376
157. Giuliano AR, Tortolero-Luna G, Ferrer E et al. (2008). Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine, 26: Suppl 10K17-K28. doi:10.1016/j.vaccine. 2008.06.021 PMID:18847554
158. Goodwin EC & DiMaio D (2000). Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Proc Natl Acad Sci U S A, 97: 12513-12518. doi:10.1073/pnas.97.23.12513 PMID:11070078
159. Gravitt PE, Coutlée F, Iftner T et al. (2008). New technologies in cervical cancer screening. Vaccine, 26: Suppl 10K42-K52. doi:10.1016/j.vaccine.2008.05.002 PMID:18847556
160. Gudleviciene Z, Didziapetriene J, Ramael M et al. (2006). Human papillomavirus and p53 polymorphism in Lithuanian cervical cancer patients. Gynecol Oncol, 102: 530-533. doi:10.1016/j.ygyno.2006.01.019 PMID:16488468
161. Guerrero D, Guarch R, Ojer A et al. (2008). Hypermethylation of the thrombospondin-1 gene is associated with poor prognosis in penile squamous cell carcinoma. BJU Int, 102: 747-755. doi:10.1111/j.1464-410X.2008.07603.x PMID:18336597
162. Gungor A, Cincik H, Baloglu H et al. (2007). Human papilloma virus prevalence in laryngeal squamous cell carcinoma. J Laryngol Otol, 121: 772-774. doi:10.1017/S0022215107006482 PMID:17320003
163. Guo M, Sneige N, Silva EG et al. (2007). Distribution and viral load of eight oncogenic types of human papillomavirus (HPV) and HPV 16 integration status in cervical intraepithelial neoplasia and carcinoma. Mod Pathol, 20: 256-266. doi:10.1038/modpathol.3800737 PMID:17192787
164. Gustafsson AC, Ren ZP, Asplund A et al. (2004). The role of p53 codon 72 and human papilloma virus status of cutaneous squamous cell carcinoma in the Swedish population. Acta Derm Venereol, 84: 439-444. doi:10.1080/00015550410021673 PMID:15844633
165. Hadzisejdć I, Krasević M, Haller H, Grahovac B (2007). Distribution of human papillomavirus types in different histological subtypes of cervical adenocarcinoma. Coll Antropol, 31: Suppl 297-102. PMID:17600937
166. Hammarstedt L, Lindquist D, Dahlstrand H et al. (2006). Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer, 119: 2620-2623. doi:10.1002/ijc.22177 PMID:16991119
167. Hampl M, Sarajuuri H, Wentzensen N et al. (2006). Effect of human papillomavirus vaccines on vulvar, vaginal, and anal intraepithelial lesions and vulvar cancer. Obstet Gynecol, 108: 1361-1368. doi:10.1097/01. AOG.0000245786.86267.80 PMID:17138767
168. Handisurya A, Rieger A, Bankier A et al. (2007). Human papillomavirus type 26 infection causing multiple invasive squamous cell carcinomas of the fingernails in an AIDS patient under highly active antiretroviral therapy. Br J Dermatol, 157: 788-794. doi:10.1111/j.1365-2133.2007.08094.x PMID:17634082
169. Hannaford PC, Selvaraj S, Elliott AM et al. (2007). Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study. BMJ, 335: 651-658. doi:10.1136/bmj.39289.649410.55 PMID:17855280
170. Hansson BG, Rosenquist K, Antonsson A et al. (2005). Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Acta Otolaryngol, 125: 1337-1344. doi:10.1080/00016480510043945 PMID:16303684
171. Harper JW, Adami GR, Wei N et al. (1993). The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75: 805-816. doi:10.1016/0092-8674(93)90499-G PMID:8242751
172. Harris TG, Kulasingam SL, Kiviat NB et al. (2004). Cigarette smoking, oncogenic human papillomavirus, Ki-67 antigen, and cervical intraepithelial neoplasia. Am J Epidemiol, 159: 834-842. doi:10.1093/aje/kwh115 PMID:15105176
173. Hasan UA, Bates E, Takeshita F et al. (2007). TLR9 expression and function is abolished by the cervical cancerassociated human papillomavirus type 16. J Immunol, 178: 3186-3197. PMID:17312167
174. Hashida T & Yasumoto S (1991). Induction of chromosome abnormalities in mouse and human epidermal keratinocytes by the human papillomavirus type 16 E7 oncogene. J Gen Virol, 72: 1569-1577. doi:10.1099/0022-1317-72-7-1569 PMID:1649895
175. Hawley-Nelson P, Vousden KH, Hubbert NL et al. (1989). HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J, 8: 3905-3910. PMID:2555178
176. Hennig EM, Suo Z, Thoresen S et al. (1999). Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (CIN III). Breast Cancer Res Treat, 53: 121-135. doi:10.1023/A:1006162609420 PMID:10326789
177. Herbst AL & Anderson D (1990). Clear cell adenocarcinoma of the vagina and cervix secondary to intrauter- ine exposure to diethylstilbestrol. Semin Surg Oncol, 6: 343-346. doi:10.1002/ssu.2980060609 PMID:2263810
178. Herrero R, Brinton LA, Reeves WC et al. (1990). Injectable contraceptives and risk of invasive cervical cancer: evidence of an association. Int J Cancer, 46: 5-7. doi:10.1002/ijc.2910460103 PMID:2163991
179. Herrero R, Castellsagué X, Pawlita M et al. IARC Multicenter Oral Cancer Study Group. (2003). Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst, 95: 1772-1783. PMID:14652239
180. Hildesheim A, Han CL, Brinton LA et al. (1997). Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: results from a seroepidemiological case-control study. Obstet Gynecol, 90: 748-754. doi:10.1016/S0029-7844(97)00467-5 PMID:9351758
181. Hildesheim A, Herrero R, Castle PE et al. (2001). HPV cofactors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer, 84: 1219-1226. doi:10.1054/bjoc.2001.1779 PMID:11336474
182. Hildesheim A, Mann V, Brinton LA et al. (1991). Herpes simplex virus type 2: a possible interaction with human papillomavirus types 16/18 in the development of invasive cervical cancer. Int J Cancer, 49: 335-340. doi:10.1002/ijc.2910490304 PMID:1655658
183. Hiller T, Poppelreuther S, Stubenrauch F, Iftner T (2006). Comparative analysis of 19 genital human papillomavirus types with regard to p53 degradation, immortalization, phylogeny, and epidemiologic risk classification. Cancer Epidemiol Biomarkers Prev, 15: 1262-1267. doi:10.1158/1055-9965.EPI-05-0778 PMID:16835321
184. Hindryckx P, Garcia A, Claeys P et al. (2006). Prevalence of high risk human papillomavirus types among Nicaraguan women with histological proved preneoplastic and neoplastic lesions of the cervix. Sex Transm Infect, 82: 334-336. doi:10.1136/sti.2006.019745 PMID:16877588
185. Ho GY, Kadish AS, Burk RD et al. (1998a). HPV 16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasia. Int J Cancer, 78: 281-285. doi:10.1002/(SICI)1097-0215(19981029)78:3<281::AIDIJC3>3.0.CO;2-R PMID:9766558
186. Ho GY, Palan PR, Basu J et al. (1998b). Viral characteristics of human papillomavirus infection and antioxidant levels as risk factors for cervical dysplasia. Int J Cancer, 78: 594-599. doi:10.1002/(SICI)1097-0215(19981123)78:5<594::AID-IJC11>3.0.CO;2-B PMID:9808528
187. Hong D, Ye F, Chen H et al. (2008). Distribution of human papillomavirus genotypes in the patients with cervical carcinoma and its precursors in Zhejiang Province, China. Int J Gynecol Cancer, 18: 104-109. doi:10.1111/j.1525-1438.2007.00968.x PMID:17466048
188. Huh K, Zhou X, Hayakawa H et al. (2007). Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor. J Virol, 81: 9737-9747. doi:10.1128/JVI.00881-07 PMID:17609271
189. IARC. (1995). Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum, 64: 1-378. PMID:16755705
190. IARC. (2007). Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum, 90: 1-636. PMID:18354839
191. IARC. (2011). Pharmaceuticals. IARC Monogr Eval Carcinog Risks Hum, 100A
192. Inoue M, Sakaguchi J, Sasagawa T, Tango M (2006). The evaluation of human papillomavirus DNA testing in primary screening for cervical lesions in a large Japanese population. Int J Gynecol Cancer, 16: 1007-1013. doi:10.1111/j.1525-1438.2006.00460.x PMID:16803477
193. Insinga RP, Liaw KL, Johnson LG, Madeleine MM (2008). A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States. Cancer Epidemiol Biomarkers Prev, 17: 1611-1622. doi:10.1158/1055-9965.EPI-07-2922 PMID:18628412
194. Jabbar SF, Abrams L, Glick A, Lambert PF (2009). Persistence of high-grade cervical dysplasia and cervical cancer requires the continuous expression of the human papillomavirus type 16 E7 oncogene. Cancer Res, 69: 4407-4414. doi:10.1158/0008-5472.CAN-09-0023 PMID:19435895
195. Jackson S, Harwood C, Thomas M et al. (2000). Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev, 14: 3065-3073. doi:10.1101/gad.182100 PMID:11114894
196. Jain N, Singh V, Hedau S et al. (2005). Infection of human papillomavirus type 18 and p53 codon 72 polymorphism in lung cancer patients from India. Chest, 128: 3999-4007. doi:10.1378/chest.128.6.3999 PMID:16354872
197. James MA, Lee JH, Klingelhutz AJ (2006). HPV16-E6 associated hTERT promoter acetylation is E6AP dependent, increased in later passage cells and enhanced by loss of p300. Int J Cancer, 119: 1878-1885. doi:10.1002/ijc.22064 PMID:16708385
198. Jha PK, Beral V, Peto J et al. (1993). Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk. Lancet, 341: 1116-1119. doi:10.1016/0140-6736(93)93128-N PMID:8097804
199. Jones DL, Alani RM, Münger K (1997). The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. Genes Dev, 11: 2101-2111. doi:10.1101/gad.11.16.2101 PMID:9284049
200. Joura EA, Leodolter S, Hernandez-Avila M et al. (2007). Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet, 369: 1693-1702. doi:10.1016/S0140-6736(07)60777-6 PMID:17512854
201. Kabsch K & Alonso A (2002). The human papillomavirus type 16 E5 protein impairs TRAIL- and FasL-mediated apoptosis in HaCaT cells by different mechanisms. J Virol, 76: 12162-12172. doi:10.1128/JVI.76.23.12162-12172.2002 PMID:12414956
202. Kagawa R, Yamaguchi T, Furuta R (2006). Histological features of human papilloma virus 16 and its association with the development and progression of anal squamous cell carcinoma. Surg Today, 36: 885-891. doi:10.1007/s00595-006-3266-x PMID:16998682
203. Kamangar F, Qiao YL, Schiller JT et al. (2006). Human papillomavirus serology and the risk of esophageal and gastric cancers: results from a cohort in a high-risk region in China. Int J Cancer, 119: 579-584. doi:10.1002/ijc.21871 PMID:16496409
204. Kanda T, Furuno A, Yoshiike K (1988). Human papillomavirus type 16 open reading frame E7 encodes a transforming gene for rat 3Y1 cells. J Virol, 62: 610-613. PMID:2826818
205. Karagas MR, Nelson HH, Sehr P et al. (2006). Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst, 98: 389-395. doi:10.1093/jnci/djj092 PMID:16537831
206. Kessis TD, Slebos RJ, Nelson WG et al. (1993). Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc Natl Acad Sci U S A, 90: 3988-3992. doi:10.1073/pnas.90.9.3988 PMID:8387205
207. Khan MJ, Castle PE, Lorincz AT et al. (2005). The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst, 97: 1072-1079. doi:10.1093/jnci/dji187 PMID:16030305
208. Khan S, Jaffer NN, Khan MN et al. (2007). Human papillomavirus subtype 16 is common in Pakistani women with cervical carcinoma. Int J Infect Dis, 11: 313-317. doi:10.1016/j.ijid.2006.06.007 PMID:17291804
209. Kim JY, Yoon JK, Citardi MJ et al. (2007b). The prevalence of human papilloma virus infection in sinonasal inverted papilloma specimens classified by histological grade. Am J Rhinol, 21: 664-669. doi:10.2500/ajr.2007.21.3093 PMID:18201444
210. Kim SH, Koo BS, Kang S et al. (2007a). HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation. Int J Cancer, 120: page 1418-1425. doi:10.1002/ijc.22464 PMID:17205528
211. Kiyono T, Hiraiwa A, Ishibashi M (1992). Differences in transforming activity and coded amino acid sequence among E6 genes of several papillomaviruses associated with epidermodysplasia verruciformis. Virology, 186: 628-639. doi:10.1016/0042-6822(92)90029-O PMID:1310189
212. Kjaer SK, Breugelmans G, Munk C et al. (2008). Populationbased prevalence, type- and age-specific distribution of HPV in women before introduction of an HPVvaccination program in Denmark. Int J Cancer, 123: 1864-1870. doi:10.1002/ijc.23712 PMID:18661520
213. Kjaer SK, Sigurdsson K, Iversen OE et al. (2009). A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions. Cancer Prev Res (Phila), 2: 868-878. doi:10.1158/1940-6207.CAPR-09-0031 PMID:19789295
214. Kjær SK, van den Brule AJ, Bock JE et al. (1996). Human papillomavirus-the most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer, 65: 601-606. doi:10.1002/(SICI)1097-0215(19960301)65:53.0.CO;2-6 PMID:8598310
215. Kjellberg L, Hallmans G, Ahren AM et al. (2000). Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection. Br J Cancer, 82: 1332-1338. PMID:10755410
216. Klingelhutz AJ, Foster SA, McDougall JK (1996). Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature, 380: 79-82. doi:10.1038/380079a0 PMID:8598912
217. Klug SJ, Hukelmann M, Hollwitz B et al. (2007). Prevalence of human papillomavirus types in women screened by cytology in Germany. J Med Virol, 79: 616-625. doi:10.1002/jmv.20863 PMID:17385693
218. Klussmann JP, Gültekin E, Weissenborn SJ et al. (2003). Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol, 162: 747-753. doi:10.1016/S0002-9440(10)63871-0 PMID:12598309
219. Koh JS, Lee SS, Baek HJ, Kim YI (2008). No association of high-risk human papillomavirus with esophageal squamous cell carcinomas among Koreans, as determined by polymerase chain reaction. Dis Esophagus, 21: 114-117. doi:10.1111/j.1442-2050.2007.00726.x PMID:18269645
220. Kong CS, Welton ML, Longacre TA (2007). Role of human papillomavirus in squamous cell metaplasiadysplasia- carcinoma of the rectum. Am J Surg Pathol, 31: 919-925. doi:10.1097/01.pas.0000213441.86030.fc PMID:17527081
221. Koppikar P, deVilliers EM, Mulherkar R (2005). Identification of human papillomaviruses in tumors of the oral cavity in an Indian community. Int J Cancer, 113: 946-950. doi:10.1002/ijc.20664 PMID:15514945
222. Korodi Z, Dillner J, Jellum E et al. (2005). Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: a Nordic nested case-control study. Cancer Epidemiol Biomarkers Prev, 14: 2952-2955. doi:10.1158/1055-9965.EPI-05-0602 PMID:16365015
223. Koshiol J, Lindsay L, Pimenta JM et al. (2008). Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol, 168: 123-137. doi:10.1093/aje/kwn036 PMID:18483125
224. Koskinen WJ, Brøndbo K, Mellin Dahlstrand H et al. (2007). Alcohol, smoking and human papillomavirus in laryngeal carcinoma: a Nordic prospective multicenter study. J Cancer Res Clin Oncol, 133: 673-678. doi:10.1007/s00432-007-0219-8 PMID:17486368
225. Koutsky LA, Holmes KK, Critchlow CW et al. (1992). A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med, 327: 1272-1278. doi:10.1056/NEJM199210293271804 PMID:1328880
226. Kovacic MB, Castle PE, Herrero R et al. (2006). Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality. Cancer Res, 66: 10112-10119. doi:10.1158/0008-5472. CAN-06-1812 PMID:17047075
227. Kreimer AR, Clifford GM, Boyle P, Franceschi S (2005). Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev, 14: 467-475. doi:10.1158/1055-9965.EPI-04-0551 PMID:15734974
228. Krüger-Kjaer S, van den Brule AJ, Svare EI et al. (1998). Different risk factor patterns for high-grade and lowgrade intraepithelial lesions on the cervix among HPV-positive and HPV-negative young women. Int J Cancer, 76: 613-619. doi:10.1002/(SICI)1097-0215(19980529)76:5<613::AID-IJC1>3.0.CO;2-T PMID:9610715
229. Kulmala SM, Shabalova IP, Petrovitchev N et al. NIS Study Group. (2007). Prevalence of the most common highrisk HPV genotypes among women in three new independent states of the former Soviet Union. J Med Virol, 79: 771-781. doi:10.1002/jmv.20839 PMID:17457909
230. Lacey JV Jr, Brinton LA, Abbas FM et al. (1999). Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev, 8: 1079-1085. PMID:10613340
231. Lacey JV Jr, Brinton LA, Barnes WA et al. (2000). Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix. Gynecol Oncol, 77: 149-154. doi:10.1006/gyno.2000.5731 PMID:10739704
232. Laco J, Slaninka I, Jirásek M et al. (2008). High-risk human papillomavirus infection and p16INK4a protein expression in laryngeal lesions. Pathol Res Pract, 204: 545-552. doi:10.1016/j.prp.2008.03.001 PMID:18440161
233. Lai CH, Chang CJ, Huang HJ et al. (2007a). Role of human papillomavirus genotype in prognosis of early-stage cervical cancer undergoing primary surgery. J Clin Oncol, 25: 3628-3634. doi:10.1200/JCO.2007.11.2995 PMID:17704412
234. Lai CH, Huang HJ, Hsueh S et al. (2007b). Human papillomavirus genotype in cervical cancer: a populationbased study. Int J Cancer, 120: 1999-2006. doi:10.1002/ijc.22538 PMID:17266033
235. Laytragoon-Lewin N, Nilsson PJ, Castro J et al. (2007). Human papillomavirus (HPV), DNA aberrations and cell cycle progression in anal squamous cell carcinoma patients. Anticancer Res, 27: 6C4473-4479. PMID:18214063
236. Lee HS, Kim KM, Kim SM et al. (2007). Human papillomavirus genotyping using HPV DNA chip analysis in Korean women. Int J Gynecol Cancer, 17: 497-501. doi:10.1111/j.1525-1438.2007.00871.x PMID:17316356
237. Leiros GJ, Galliano SR, Sember ME et al. (2005). Detection of human papillomavirus DNA and p53 codon 72 polymorphism in prostate carcinomas of patients from Argentina. BMC Urol, 5: 15 doi:10.1186/1471-2490-5-15 PMID:16307686
238. Li S, Labrecque S, Gauzzi MC et al. (1999). The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha. Oncogene, 18: 5727-5737. doi:10.1038/sj.onc.1202960 PMID:10523853
239. Liang XH, Lewis J, Foote R et al. (2008). Prevalence and significance of human papillomavirus in oral tongue cancer: the Mayo Clinic experience. J Oral Maxillofac Surg, 66: 1875-1880. doi:10.1016/j.joms.2008.04.009 PMID:18718395
240. Lindel K, Forster A, Altermatt HJ et al. (2007). Breast cancer and human papillomavirus (HPV) infection: no evidence of a viral etiology in a group of Swiss women. Breast, 16: 172-177. doi:10.1016/j.breast.2006.09.001 PMID:17088061
241. Liu X, Liu GB, Pang ZJ, Xing FQ (2005). Sequence polymorphism of human papillomavirus type 16 E7 in cervical cancer Di Yi Jun Yi Da Xue Xue Bao, 25: 1272-1275. PMID:16234107
242. Longworth MS, Wilson R, Laimins LA (2005). HPV31 E7 facilitates replication by activating E2F2 transcription through its interaction with HDACs. EMBO J, 24: 1821-1830. doi:10.1038/sj.emboj.7600651 PMID:15861133
243. Lont AP, Kroon BK, Horenblas S et al. (2006). Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival. Int J Cancer, 119: 1078-1081. doi:10.1002/ijc.21961 PMID:16570278
244. Lu DW, El-Mofty SK, Wang HL (2003). Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA. Mod Pathol, 16: 692-699. doi:10.1097/01. MP.0000077417.08371.CE PMID:12861066
245. Lu XM, Monnier-Benoit S, Mo LZ et al. (2008). Human papillomavirus in esophageal squamous cell carci- noma of the high-risk Kazakh ethnic group in Xinjiang, China. Eur J Surg Oncol, 34: 765-770. PMID:18160246
246. Luo CW, Roan CH, Liu CJ (2007). Human papillomaviruses in oral squamous cell carcinoma and pre-cancerous lesions detected by PCR-based gene-chip array. Int J Oral Maxillofac Surg, 36: 153-158. doi:10.1016/j. ijom.2006.09.005 PMID:17110084
247. Lüscher-Firzlaff JM, Westendorf JM, Zwicker J et al. (1999). Interaction of the fork head domain transcription factor MPP2 with the human papilloma virus 16 E7 protein: enhancement of transformation and transactivation. Oncogene, 18: 5620-5630. doi:10.1038/sj.onc.1202967 PMID:10523841
248. Madeleine MM, Brumback B, Cushing-Haugen KL et al. (2002). Human leukocyte antigen class II and cervical cancer risk: a population-based study. J Infect Dis, 186: 1565-1574. doi:10.1086/345285 PMID:12447731
249. Madeleine MM, Daling JR, Carter JJ et al. (1997). Cofactors with human papillomavirus in a populationbased study of vulvar cancer. J Natl Cancer Inst, 89: 1516-1523. doi:10.1093/jnci/89.20.1516 PMID:9337348
250. Madsen BS, Jensen HL, van den Brule AJ et al. (2008). Risk factors for invasive squamous cell carcinoma of the vulva and vagina-population-based case-control study in Denmark. Int J Cancer, 122: 2827-2834. doi:10.1002/ijc.23446 PMID:18348142
251. Maehama T (2005). Epidemiological study in Okinawa, Japan, of human papillomavirus infection of the uterine cervix. Infect Dis Obstet Gynecol, 13: 77-80. doi:10.1080/10647440400028151 PMID:16011997
252. Majewski S & Jablonska S (2006). Current views on the role of human papillomaviruses in cutaneous oncogenesis. Int J Dermatol, 45: 192-196. doi:10.1111/j.1365-4632.2006.02758.x PMID:16533214
253. Mantovani F & Banks L (2001). The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene, 20: 7874-7887. doi:10.1038/sj.onc.1204869 PMID:11753670
254. Masini C, Fuchs PG, Gabrielli F et al. (2003). Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals. Arch Dermatol, 139: 890-894. doi:10.1001/archderm.139.7.890 PMID:12873884
255. Massimi P, Thomas M, Bouvard V et al. (2008). Comparative transforming potential of different human papillomaviruses associated with non-melanoma skin cancer. Virology, 371: 374-379. doi:10.1016/j.virol.2007.10.015 PMID:17997466
256. Matlashewski G, Schneider J, Banks L et al. (1987). Human papillomavirus type 16 DNA cooperates with activated ras in transforming primary cells. EMBO J, 6: 1741-1746. PMID:3038534
257. Maucort-Boulch D, Franceschi S, Plummer MIARC HPV Prevalence Surveys Study Group. (2008). International correlation between human papillomavirus prevalence and cervical cancer incidence. Cancer Epidemiol Biomarkers Prev, 17: 717-720. doi:10.1158/1055-9965. EPI-07-2691 PMID:18349293
258. Maufort JP, Williams SM, Pitot HC, Lambert PF (2007). Human papillomavirus 16 E5 oncogene contributes to two stages of skin carcinogenesis. Cancer Res, 67: 6106-6112. doi:10.1158/0008-5472.CAN-07-0921 PMID:17616666
259. McCredie MR, Sharples KJ, Paul C et al. (2008). Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol, 9: 425-434.doi:10.1016/S1470-2045(08)70103-7 PMID:18407790
260. Michael KM, Waterboer T, Sehr P et al. (2008). Seroprevalence of 34 human papillomavirus types in the German general population. PLoS Pathog, 4: e1000091 doi:10.1371/journal.ppat.1000091 PMID:18566657
261. Michel A, Kopp-Schneider A, Zentgraf H et al. (2006). E6/ E7 expression of human papillomavirus type 20 (HPV- 20) and HPV-27 influences proliferation and differentiation of the skin in UV-irradiated SKH-hr1 transgenic mice. J Virol, 80: 11153-11164. doi:10.1128/JVI.00954-06 PMID:16971438
262. Miralles-Guri C, Bruni L, Cubilla AL et al. (2009). Human papillomavirus prevalence and type distribution in penile carcinoma. J Clin Pathol, 62: 870-878. doi:10.1136/jcp.2008.063149 PMID:19706632
263. Moonen PM, Bakkers JM, Kiemeney LA et al. (2007). Human papilloma virus DNA and p53 mutation analysis on bladder washes in relation to clinical outcome of bladder cancer. Eur Urol, 52: 464-469. doi:10.1016/j.eururo.2006.11.017 PMID:17116360
264. Morandell D, Rostek U, Bouvard V et al. (2008). Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression. Virology, 379: 20-29. doi:10.1016/j.virol.2008.06.004 PMID:18649911
265. Moreno V, Bosch FX, Muñoz N et al. International Agency for Research on Cancer. Multicentric Cervical Cancer Study Group. (2002). Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet, 359: 1085-1092. doi:10.1016/S0140-6736(02)08150-3 PMID:11943255
266. Moscicki AB, Schiffman M, Kjaer S, Villa LL (2006). Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine, 24: Suppl 3S3, 42-51. doi:10.1016/j.vaccine.2006.06.018 PMID:16950017
267. Münger K, Basile JR, Duensing S et al. (2001). Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene, 20: 7888-7898. doi:10.1038/sj.onc.1204860 PMID:11753671
268. Münger K, Werness BA, Dyson N et al. (1989). Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J, 8: 4099-4105. PMID:2556261
269. Muñoz N, Franceschi S, Bosetti C et al. International Agency for Research on Cancer. Multicentric Cervical Cancer Study Group. (2002). Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet, 359: 1093-1101. doi:10.1016/S0140-6736(02)08151-5 PMID:11943256
270. Muñoz N, Hernandez-Suarez G, Méndez F et al. Instituto Nacional de Cancerología HPV Study Group. (2009). Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women. Br J Cancer, 100: 1184-1190. doi:10.1038/sj.bjc.6604972 PMID:19293802
271. Nadji SA, Mokhtari-Azad T, Mahmoodi M et al. (2007). Relationship between lung cancer and human papillomavirus in north of Iran, Mazandaran province. Cancer Lett, 248: 41-46. doi:10.1016/j.canlet.2006.05.016 PMID:16814459
272. Nair HB, Luthra R, Kirma N et al. (2005). Induction of aromatase expression in cervical carcinomas: effects of endogenous estrogen on cervical cancer cell proliferation. Cancer Res, 65: 11164-11173. doi:10.1158/0008-5472.CAN-05-1087 PMID:16322267
273. Nees M, Geoghegan JM, Hyman T et al. (2001). Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaBresponsive genes in cervical keratinocytes. J Virol, 75: 4283-4296. doi:10.1128/JVI.75.9.4283-4296.2001 PMID:11287578
274. Nguyen ML, Nguyen MM, Lee D et al. (2003). The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo. J Virol, 77: 6957-6964. doi:10.1128/JVI.77.12.6957-6964.2003 PMID:12768014
275. Nominé Y, Masson M, Charbonnier S et al. (2006). Structural and functional analysis of E6 oncoprotein: insights in the molecular pathways of human papillomavirus-mediated pathogenesis. Mol Cell, 21: 665-678. doi:10.1016/j.molcel.2006.01.024 PMID:16507364
276. O'Regan EM, Toner ME, Finn SP et al. (2008). P16(INK4A) genetic and epigenetic profiles differ in relation to age and site in head and neck squamous cell carcinomas. Hum Pathol, 39: 452-458. doi:10.1016/j.humpath. 2007.08.004 PMID:18261630
277. Odida M, de Sanjosé S, Quint W et al. (2008). Human Papillomavirus type distribution in invasive cervical cancer in Uganda. BMC Infect Dis, 8: 85 doi:10.1186/1471-2334-8-85 PMID:18577214
278. Olsen AO, Dillner J, Skrondal A, Magnus P (1998a). Combined effect of smoking and human papillomavirus type 16 infection in cervical carcinogenesis. Epidemiology, 9: 346-349. doi:10.1097/00001648-199805000-00022 PMID:9583429
279. Olsen AO, Orstavik I, Dillner J et al. (1998b). Herpes simplex virus and human papillomavirus in a population-based case-control study of cervical intraepithelial neoplasia grade II-III. APMIS, 106: 417-424. doi:10.1111/j.1699-0463.1998.tb01366.x PMID:9548432
280. Pan H & Griep AE (1994). Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. Genes Dev, 8: 1285-1299. doi:10.1101/gad.8.11.1285 PMID:7926731
281. Pan H & Griep AE (1995). Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development. Genes Dev, 9: 2157-2169. doi:10.1101/gad.9.17.2157 PMID:7657167
282. Panotopoulou E, Tserkezoglou A, Kouvousi M et al. (2007). Prevalence of human papillomavirus types 6, 11, 16, 18, 31, and 33 in a cohort of Greek women. J Med Virol, 79: 1898-1905. doi:10.1002/jmv.21025 PMID:17935171
283. Pantelis A, Pantelis D, Ruemmele P et al. (2007). P53 Codon 72 polymorphism, loss of heterozygosity and high-risk human papillomavirus infection in a low-incidence German esophageal squamous cell carcinoma patient cohort. Oncol Rep, 17: 1243-1248. PMID:17390072
284. Park JS, Kim EJ, Kwon HJ et al. (2000). Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis. J Biol Chem, 275: 6764-6769. doi:10.1074/jbc.275.10.6764 PMID:10702232
285. Park MS, Chang YS, Shin JH et al. (2007). The prevalence of human papillomavirus infection in Korean nonsmall cell lung cancer patients. Yonsei Med J, 48: 69-77. doi:10.3349/ymj.2007.48.1.69 PMID:17326248
286. Pascual A, Pariente M, Godínez JM et al. (2007). High prevalence of human papillomavirus 16 in penile carcinoma. Histol Histopathol, 22: 177-183. PMID:17149690
287. Patel AS, Karagas MR, Perry AE, Nelson HH (2008). Exposure profiles and human papillomavirus infection in skin cancer: an analysis of 25 genus beta-types in a population-based study. J Invest Dermatol, 128: 2888-2893. doi:10.1038/jid.2008.162 PMID:18548109
288. Peedicayil A, Abraham P, Sathish N et al. (2006). Human papillomavirus genotypes associated with cervical neoplasia in India. Int J Gynecol Cancer, 16: 1591-1595. doi:10.1111/j.1525-1438.2006.00631.x PMID:16884371
289. Peng HQ, Liu SL, Mann V et al. (1991). Human papillomavirus types 16 and 33, herpes simplex virus type 2 and other risk factors for cervical cancer in Sichuan Province, China. Int J Cancer, 47: 711-716. doi:10.1002/ijc.2910470515 PMID:1848537
290. Perea SE, Massimi P, Banks L (2000). Human papillomavirus type 16 E7 impairs the activation of the interferon regulatory factor-1. Int J Mol Med, 5: 661-666. PMID:10812019
291. Pett MR, Alazawi WO, Roberts I et al. (2004). Acquisition of high-level chromosomal instability is associated with integration of human papillomavirus type 16 in cervical keratinocytes. Cancer Res, 64: 1359-1368. doi:10.1158/0008-5472.CAN-03-3214 PMID:14973079
292. Pfister H (2003) Chapter 8: Human papillomavirus and skin cancer. J Natl Cancer Inst Monogr, 52-56.
293. Pim D, Collins M, Banks L (1992). Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor. Oncogene, 7: 27-32. PMID:1311063
294. Piña-Sánchez P, Hernández-Hernández DM, López-Romero R et al. (2006). Human papillomavirus-specific viral types are common in Mexican women affected by cervical lesions. Int J Gynecol Cancer, 16: 1041-1047. doi:10.1111/j.1525-1438.2006.00458.x PMID:16803483
295. Pintos J, Black MJ, Sadeghi N et al. (2008). Human papillomavirus infection and oral cancer: a casecontrol study in Montreal, Canada. Oral Oncol, 44: 242-250. doi:10.1016/j.oraloncology.2007.02.005 PMID:17467327
296. Pirisi L, Yasumoto S, Feller M et al. (1987). Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J Virol, 61: 1061-1066. PMID:2434663
297. Piyathilake CJ, Macaluso M, Brill I et al. (2007). Lower red blood cell folate enhances the HPV-16-associated risk of cervical intraepithelial neoplasia. Nutrition, 23: 203-210. doi:10.1016/j.nut.2006.12.002 PMID:17276035
298. Plummer M, Herrero R, Franceschi S et al. IARC Multicentre Cervical Cancer Study Group. (2003). Smoking and cervical cancer: pooled analysis of the IARC multicentric case-control study. Cancer Causes Control, 14: 805-814. doi:10.1023/B:CACO.0000003811.98261.3e PMID:14682438
299. Popescu NC & DiPaolo JA (1990). Integration of human papillomavirus 16 DNA and genomic rearrangements in immortalized human keratinocyte lines. Cancer Res, 50: 1316-1323. PMID:2153457
300. Prétet JL, Jacquard AC, Carcopino X et al. EDITH study group. (2008). Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study. Int J Cancer, 122: 428-432. doi:10.1002/ijc.23092 PMID:17893882
301. Purdie KJ, Surentheran T, Sterling JC et al. (2005). Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppressed and immunocompetent individuals. J Invest Dermatol, 125: 98-107. doi:10.1111/j.0022-202X.2005.23635.x PMID:15982309
302. Qiu AD, Wu EQ, Yu XH et al. (2007). HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China. Gynecol Oncol, 104: 77-85. doi:10.1016/j.ygyno.2006.07.016 PMID:16970982
303. Quirk JT, Kupinski JM, DiCioccio RA (2006). Analysis of ovarian tumors for the presence of human papillomavirus DNA. J Obstet Gynaecol Res, 32: 202-205. doi:10.1111/j.1447-0756.2006.00376.x PMID:16594925
304. Rajkumar T, Franceschi S, Vaccarella S et al. (2003). Role of paan chewing and dietary habits in cervical carcinoma in Chennai, India. Br J Cancer, 88: 1388-1393. doi:10.1038/sj.bjc.6600902 PMID:12778066
305. Reimers N, Kasper HU, Weissenborn SJ et al. (2007). Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer, 120: 1731-1738. doi:10.1002/ijc.22355 PMID:17236202
306. Ressler S, Scheiden R, Dreier K et al. (2007). High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma. Clin Cancer Res, 13: 7067-7072. doi:10.1158/1078-0432.CCR-07-1222 PMID:18056184
307. Riley RR, Duensing S, Brake T et al. (2003). Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis. Cancer Res, 63: 4862-4871. PMID:12941807
308. Rodríguez AC, Schiffman M, Herrero R et al. Proyecto Epidemiológico Guanacaste Group. (2008). Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. J Natl Cancer Inst, 100: 513-517. doi:10.1093/jnci/djn044 PMID:18364507
309. Ronco LV, Karpova AY, Vidal M, Howley PM (1998). Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev, 12: 2061-2072. doi:10.1101/gad.12.13.2061 PMID:9649509
310. Rosenblatt KA, Carter JJ, Iwasaki LM et al. (2003). Serologic evidence of human papillomavirus 16 and 18 infections and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev, 12: 763-768. PMID:12917208
311. Rubin MA, Kleter B, Zhou M et al. (2001). Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol, 159: 1211-1218. doi:10.1016/S0002-9440(10)62506-0 PMID:11583947
312. Sagerman PM, Choi YJ, Hu Y, Niedt GW (1996). Human papilloma virus, vulvar dystrophy, and vulvar carcinoma: differential expression of human papillomavirus and vulvar dystrophy in the presence and absence of squamous cell carcinoma of the vulva. Gynecol Oncol, 61: 328-332. doi:10.1006/gyno.1996.0151 PMID:8641610
313. Salazar EL, Mercado E, Calzada L (2005). Human papillomavirus hpv-16 DNA as an epitheliotropic virus that induces hyperproliferation in squamous penile tissue. Arch Androl, 51: 327-334. doi:10.1080/014850190923396 PMID:16036641
314. Sato H, Furuno A, Yoshiike K (1989). Expression of human papillomavirus type 16 E7 gene induces DNA synthesis of rat 3Y1 cells. Virology, 168: 195-199. doi:10.1016/0042-6822(89)90423-6 PMID:2535904
315. Schaper ID, Marcuzzi GP, Weissenborn SJ et al. (2005). Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8. Cancer Res, 65: 1394-1400. doi:10.1158/0008-5472.CAN-04-3263 PMID:15735026
316. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM (1993). The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell, 75: 495-505. doi:10.1016/0092-8674(93)90384-3 PMID:8221889
317. Scheffner M, Werness BA, Huibregtse JM et al. (1990). The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell, 63: 1129-1136. doi:10.1016/0092-8674(90)90409-8 PMID:2175676
318. Schiff M, Becker TM, Masuk M et al. (2000). Risk factors for cervical intraepithelial neoplasia in southwestern American Indian women. Am J Epidemiol, 152: 716-726. doi:10.1093/aje/152.8.716 PMID:11052549
319. Schiffman M, Castle PE, Jeronimo J et al. (2007). Human papillomavirus and cervical cancer. Lancet, 370: 890-907. doi:10.1016/S0140-6736(07)61416-0 PMID:17826171
320. Schiffman M, Khan MJ, Solomon D et al. PEG Group; ALTS Group. (2005). A study of the impact of adding HPV types to cervical cancer screening and triage tests. J Natl Cancer Inst, 97: 147-150. doi:10.1093/jnci/dji014 PMID:15657345
321. Schiffman M & Rodríguez AC (2008). Heterogeneity in CIN3 diagnosis. Lancet Oncol, 9: 404-406. doi:10.1016/S1470-2045(08)70110-4 PMID:18452848
322. Schmitt A, Harry JB, Rapp B et al. (1994). Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1. J Virol, 68: 7051-7059. PMID:7933087
323. Schwartz SM, Daling JR, Doody DR et al. (1998). Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst, 90: 1626-1636. doi:10.1093/jnci/90.21.1626 PMID:9811312
324. Schwarz E, Freese UK, Gissmann L et al. (1985). Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature, 314: 111-114. doi:10.1038/314111a0 PMID:2983228
325. Seavey SE, Holubar M, Saucedo LJ, Perry ME (1999). The E7 oncoprotein of human papillomavirus type 16 stabilizes p53 through a mechanism independent of p19(ARF). J Virol, 73: 7590-7598. PMID:10438849
326. Sedjo RL, Inserra P, Abrahamsen M et al. (2002). Human papillomavirus persistence and nutrients involved in the methylation pathway among a cohort of young women. Cancer Epidemiol Biomarkers Prev, 11: 353-359. PMID:11927495
327. Sedman SA, Barbosa MS, Vass WC et al. (1991). The fulllength E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture. J Virol, 65: 4860-4866. PMID:1651408
328. Sekaric P, Cherry JJ, Androphy EJ (2008). Binding of human papillomavirus type 16 E6 to E6AP is not required for activation of hTERT. J Virol, 82: 71-76. doi:10.1128/JVI.01776-07 PMID:17942561
329. Senkus-Konefka E, Konefka T, Jassem J (2004). The effects of tamoxifen on the female genital tract. Cancer Treat Rev, 30: 291-301. doi:10.1016/j.ctrv.2003.09.004 PMID:15059652
330. Shai A, Brake T, Somoza C, Lambert PF (2007). The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities. Cancer Res, 67: 1626-1635.doi:10.1158/0008-5472.CAN-06-3344 PMID:17308103
331. Shai A, Pitot HC, Lambert PF (2008). P53 Loss synergizes with estrogen and papillomaviral oncogenes to induce cervical and breast cancers. Cancer Res, 68: 2622-2631. doi:10.1158/0008-5472.CAN-07-5266 PMID:18413729
332. Shamanin VA, Sekaric P, Androphy EJ (2008). HAda3 degradation by papillomavirus type 16 E6 correlates with abrogation of the p14ARF-p53 pathway and efficient immortalization of human mammary epithelial cells. J Virol, 82: 3912-3920. doi:10.1128/JVI.02466-07 PMID:18256148
333. Shapiro S, Rosenberg L, Hoffman M et al. (2003). Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa). Cancer Causes Control, 14: 485-495. doi:10.1023/A:1024910808307 PMID:12946044
334. Shuyama K, Castillo A, Aguayo F et al. (2007). Human papillomavirus in high- and low-risk areas of oesophageal squamous cell carcinoma in China. Br J Cancer, 96: 1554-1559. doi:10.1038/sj.bjc.6603765 PMID:17453003
335. Sigurdsson K, Taddeo FJ, Benediktsdottir KR et al. (2007). HPV genotypes in CIN 2-3 lesions and cervical cancer: a population-based study. Int J Cancer, 121: 2682-2687. doi:10.1002/ijc.23034 PMID:17724723
336. Simonson SJ, Difilippantonio MJ, Lambert PF (2005). Two distinct activities contribute to human papillomavirus 16 E6's oncogenic potential. Cancer Res, 65: 8266-8273. doi:10.1158/0008-5472.CAN-05-1651 PMID:16166303
337. Siriaunkgul S, Suwiwat S, Settakorn J et al. (2008). HPV genotyping in cervical cancer in Northern Thailand: adapting the linear array HPV assay for use on paraffin-embedded tissue. Gynecol Oncol, 108: 555-560. doi:10.1016/j.ygyno.2007.11.016 PMID:18199473
338. Sitas F, Urban M, Stein L et al. (2007). The relationship between anti-HPV-16 IgG seropositivity and cancer of the cervix, anogenital organs, oral cavity and pharynx, oesophagus and prostate in a black South African population. Infect Agent Cancer, 2: 6 doi:10.1186/1750-9378-2-6 PMID:17331260
339. Slebos RJ, Lee MH, Plunkett BS et al. (1994). P53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc Natl Acad Sci U S A, 91: 5320-5324. doi:10.1073/pnas.91.12.5320 PMID:8202487
340. Smith EM, Ritchie JM, Summersgill KF et al. (2004). Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer, 108: 766-772. doi:10.1002/ijc.11633 PMID:14696105
341. Smith JS, Herrero R, Bosetti C et al. International Agency for Research on Cancer (IARC) Multicentric Cervical Cancer Study Group. (2002b). Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst, 94: 1604-1613. PMID:12419786
342. Smith JS, Lindsay L, Hoots B et al. (2007). Human papillomavirus ype distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer, 121: 621-632. doi:10.1002/ijc.22527PMID:17405118
343. Smith JS, Muñoz N, Herrero R et al. (2002a). Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis, 185: 324-331. doi:10.1086/338569 PMID:11807714
344. Smith PP, Bryant EM, Kaur P, McDougall JK (1989). Cytogenetic analysis of eight human papillomavirus immortalized human keratinocyte cell lines. Int J Cancer, 44: 1124-1131. doi:10.1002/ijc.2910440631 PMID:2558081
345. Smotkin D & Wettstein FO (1986). Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. Proc Natl Acad Sci U S A, 83: 4680-4684. doi:10.1073/pnas.83.13.4680 PMID:3014503
346. Soares RC, Oliveira MC, Souza LB et al. (2007). Human papillomavirus in oral squamous cells carcinoma in a population of 75 Brazilian patients. Am J Otolaryngol, 28: 397-400. doi:10.1016/j.amjoto.2006.11.012 PMID:17980772
347. Song ES, Lee HJ, Hwang TS (2007). Clinical efficacy of human papillomavirus DNA detection in urine from patients with various cervical lesions. J Korean Med Sci, 22: 99-104. doi:10.3346/jkms.2007.22.1.99 PMID:17297259
348. Song S, Gulliver GA, Lambert PF (1998). Human papillomavirus type 16 E6 and E7 oncogenes abrogate radiation- induced DNA damage responses in vivo through p53-dependent and p53-independent pathways. Proc Natl Acad Sci U S A, 95: 2290-2295. doi:10.1073/pnas.95.5.2290 PMID:9482878
349. Souto Damin AP, Guedes Frazzon AP, de Carvalho Damin D et al. (2006). Detection of human papillomavirus DNA in squamous cell carcinoma of the esophagus by auto-nested PCR. Dis Esophagus, 19: 64-68. doi:10.1111/j.1442-2050.2006.00541.x PMID:16643171
350. Sowjanya AP, Jain M, Poli UR et al. (2005). Prevalence and distribution of high-risk human papilloma virus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India. BMC Infect Dis, 5: 116 doi:10.1186/1471-2334-5-116 PMID:16371167
351. Spandidos DA, Dokianakis DN, Kallergi G, Aggelakis E (2000). Molecular basis of gynecological cancer. Ann N Y Acad Sci, 900: 56-64. doi:10.1111/j.1749-6632.2000.tb06216.x PMID:10818392
352. Spanos WC, Hoover A, Harris GF et al. (2008). The PDZ binding motif of human papillomavirus type 16 E6 induces PTPN13 loss, which allows anchorage-independent growth and synergizes with ras for invasive growth. J Virol, 82: 2493-2500. doi:10.1128/JVI.02188-07 PMID:18160445
353. Sriamporn S, Snijders PJ, Pientong C et al. (2006). Human papillomavirus and cervical cancer from a prospective study in Khon Kaen, Northeast Thailand. Int J Gynecol Cancer, 16: 266-269. doi:10.1111/j.1525-1438.2006.00356.x PMID:16445643
354. Steele C, Sacks PG, Adler-Storthz K, Shillitoe EJ (1992). Effect on cancer cells of plasmids that express antisense RNA of human papillomavirus type 18. Cancer Res, 52: 4706-4711. PMID:1324791
355. Steenbergen RD, Hermsen MA, Walboomers JM et al. (1998). Non-random allelic losses at 3p, 11p and 13q during HPV-mediated immortalization and concomitant loss of terminal differentiation of human keratinocytes. Int J Cancer, 76: 412-417. doi:10.1002/(SICI)1097-0215(19980504)76:3<412::AID-IJC20>3.0.CO;2-B PMID:9579580
356. Stevens MP, Tabrizi SN, Quinn MA, Garland SM (2006). Human papillomavirus genotype prevalence in cervical biopsies from women diagnosed with cervical intraepithelial neoplasia or cervical cancer in Melbourne, Australia. Int J Gynecol Cancer, 16: 1017-1024. doi:10.1111/j.1525-1438.2006.00453.x PMID:16803479
357. Storey A & Banks L (1993). Human papillomavirus type 16 E6 gene cooperates with EJ-ras to immortalize primary mouse cells. Oncogene, 8: 919-924. PMID:8384359
358. Storey A, Pim D, Murray A et al. (1988). Comparison of the in vitro transforming activities of human papillomavirus types. EMBO J, 7: 1815-1820. PMID:2458921
359. Straight SW, Herman B, McCance DJ (1995). The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes. J Virol, 69: 3185-3192. PMID:7707548
360. Straight SW, Hinkle PM, Jewers RJ, McCance DJ (1993). The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes. J Virol, 67: 4521-4532. PMID:8392596
361. Strati K & Lambert PF (2007). Role of Rb-dependent and Rb-independent functions of papillomavirus E7 oncogene in head and neck cancer. Cancer Res, 67: 11585-11593. doi:10.1158/0008-5472.CAN-07-3007 PMID:18089787
362. Strati K, Pitot HC, Lambert PF (2006). Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model. Proc Natl Acad Sci U S A, 103: 14152-14157. doi:10.1073/pnas.0606698103 PMID:16959885
363. Struijk L, Hall L, van der Meijden E et al. (2006). Markers of cutaneous human papillomavirus infection in individuals with tumor-free skin, actinic keratoses, and squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev, 15: 529-535. doi:10.1158/1055-9965.EPI-05-0747 PMID:16537712
364. Su TH, Chang TY, Lee YJ et al. (2007). CTLA-4 gene and susceptibility to human papillomavirus-16-associated cervical squamous cell carcinoma in Taiwanese women. Carcinogenesis, 28: 1237-1240. doi:10.1093/carcin/bgm043 PMID:17341658
365. Sutcliffe S, Giovannucci E, Gaydos CA et al. (2007). Plasma antibodies against Chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: a prospective study. Cancer Epidemiol Biomarkers Prev, 16: 1573-1580. doi:10.1158/1055-9965.EPI-07-0134 PMID:17684131
366. Tachezy R, Jirasek T, Salakova M et al. (2007). Human papillomavirus infection and tumours of the anal canal: correlation of histology, PCR detection in paraffin sections and serology. APMIS, 115: 195-203. doi:10.1111/j.1600-0463.2007.apm_526.x PMID:17367464
367. Tachezy R, Klozar J, Saláková M et al. (2005). HPV and other risk factors of oral cavity/oropharyngeal cancer in the Czech Republic. Oral Dis, 11: 181-185. doi:10.1111/j.1601-0825.2005.01112.x PMID:15888110
368. Tao PP, Bian ML, Ou H et al. (2006). Application research on the flow-through hybridization and gene chip in human papillomavirus detection Zhonghua Fu Chan Ke Za Zhi, 41: 43-47. PMID:16635328
369. Tawfik El-Mansi M, Cuschieri KS, Morris RG, Williams ARW (2006). Prevalence of human papillomavirus types 16 and 18 in cervical adenocarcinoma and its precursors in Scottish patients. Int J Gynecol Cancer, 16: 1025-1031. doi:10.1111/j.1525-1438.2006.00552.x PMID:16803480
370. Termorshuizen F, Feltkamp MC, Struijk L et al. (2004). Sunlight exposure and (sero)prevalence of epidermodysplasia verruciformis-associated human papillomavirus. J Invest Dermatol, 122: 1456-1462. doi:10.1111/j.0022-202X.2004.22617.x PMID:15175037
371. Thomas JT & Laimins LA (1998). Human papillomavirus oncoproteins E6 and E7 independently abrogate the mitotic spindle checkpoint. J Virol, 72: 1131-1137. PMID:9445009
372. Thomas M & Banks L (1998). Inhibition of Bak-induced apoptosis by HPV-18 E6. Oncogene, 17: 2943-2954. doi:10.1038/sj.onc.1202223 PMID:9881696
373. Thomas M & Banks L (1999). Human papillomavirus (HPV) E6 interactions with Bak are conserved amongst E6 proteins from high and low risk HPV types. J Gen Virol, 80: 1513-1517. PMID:10374970
374. Thomas M, Narayan N, Pim D et al. (2008). Human papillomaviruses, cervical cancer and cell polarity. Oncogene, 27: 7018-7030. doi:10.1038/onc.2008.351 PMID:19029942
375. Thomas MC & Chiang CM (2005). E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation. Mol Cell, 17: 251-264. doi:10.1016/j.molcel. 2004.12.016 PMID:15664194
376. Tong SY, Lee YS, Park JS, Namkoong SE (2007). Human papillomavirus genotype as a prognostic factor in carcinoma of the uterine cervix. Int J Gynecol Cancer, 17: 1307-1313. doi:10.1111/j.1525-1438.2007.00933.x PMID:17425678
377. Tornesello ML, Duraturo ML, Botti G et al. Italian HPV Working Group. (2006). Prevalence of alpha-papillomavirus genotypes in cervical squamous intraepithelial lesions and invasive cervical carcinoma in the Italian population. J Med Virol, 78: 1663-1672. doi:10.1002/jmv.20752 PMID:17063505
378. Trottier H, Mahmud S, Prado JC et al. (2008). Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination. J Infect Dis, 197: 1436-1447. doi:10.1086/587698 PMID:18419547
379. Tsunokawa Y, Takebe N, Kasamatsu T et al. (1986). Transforming activity of human papillomavirus type 16 DNA sequence in a cervical cancer. Proc Natl Acad Sci U S A, 83: 2200-2203. doi:10.1073/pnas.83.7.2200 PMID:3008153
380. Underbrink MP, Howie HL, Bedard KM et al. (2008). E6 proteins from multiple human betapapillomavirus types degrade Bak and protect keratinocytes from apoptosis after UVB irradiation. J Virol, 82: 10408-10417. doi:10.1128/JVI.00902-08 PMID:18715924
381. van Duin M, Steenbergen RD, de Wilde J et al. (2003). Telomerase activity in high-grade cervical lesions is associated with allelic imbalance at 6Q14-22. Int J Cancer, 105: 577-582. doi:10.1002/ijc.11145 PMID:12740903
382. Varnai AD, Bollmann M, Griefingholt H et al. (2006). HPV in anal squamous cell carcinoma and anal intraepithelial neoplasia (AIN). Impact of HPV analysis of anal lesions on diagnosis and prognosis. Int J Colorectal Dis, 21: 135-142. doi:10.1007/s00384-005-0777-7 PMID:15864603
383. Vinokurova S, Wentzensen N, Kraus I et al. (2008). Typedependent integration frequency of human papillomavirus genomes in cervical lesions. Cancer Res, 68: 307-313. doi:10.1158/0008-5472.CAN-07-2754 PMID:18172324
384. Vinokurova S, Wentzensen N, von Knebel Doeberitz M (2005). Analysis of p16INK4a and integrated HPV genomes as progression markers. Methods Mol Med, 119: 73-83. PMID:16350398
385. von Knebel Doeberitz M, Oltersdorf T, Schwarz E, Gissmann L (1988). Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells. Cancer Res, 48: 3780-3786. PMID:2837324
386. von Knebel Doeberitz M, Rittmüller C, zur Hausen H, Dürst M (1992). Inhibition of tumorigenicity of cervical cancer cells in nude mice by HPV E6-E7 antisense RNA. Int J Cancer, 51: 831-834. doi:10.1002/ijc.2910510527 PMID:1319412
387. Vousden KH, Doniger J, DiPaolo JA, Lowy DR (1988). The E7 open reading frame of human papillomavirus type 16 encodes a transforming gene. Oncogene Res, 3: 167-175. PMID:2852339
388. Waterboer T, Abeni D, Sampogna F et al. (2008). Serological association of beta and gamma human papillomaviruses with squamous cell carcinoma of the skin. Br J Dermatol, 159: 457-459. doi:10.1111/j.1365-2133.2008.08621.x PMID:18503604
389. Weinstein SJ, Ziegler RG, Selhub J et al. (2001). Elevated serum homocysteine levels and increased risk of invasive cervical cancer in US women. Cancer Causes Control, 12: 317-324. doi:10.1023/A:1011290103779 PMID:11456227
390. Wentzensen N, Schiffman M, Dunn ST et al. (2009). Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in Oklahoma. Int J Cancer, 124: 964-969. doi:10.1002/ijc.23969 PMID:19030188
391. Whang JD & Lee JH (1997). Molecular genetics of gynecologic cancer. J Korean Med Sci, 12: 383-389. PMID:9364294
392. Wheeler CM, Hunt WC, Schiffman M, Castle PEAtypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study Group. (2006). Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer. J Infect Dis, 194: 1291-1299. doi:10.1086/507909 PMID:17041856
393. WHO. (2009). Meeting of the immunization strategic advisory group of experts, November 2008-conclusions and recommendations. Wkly Epidemiol Rec, 84: 1-16. PMID:19149014
394. Wideroff L, Potischman N, Glass AG et al. (1998). A nested case-control study of dietary factors and the risk of incident cytological abnormalities of the cervix. Nutr Cancer, 30: 130-136. doi:10.1080/01635589809514652 PMID:9589431
395. Winer RL, Kiviat NB, Hughes JP et al. (2005). Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis, 191: 731-738. doi:10.1086/427557 PMID:15688287
396. Woodman CB, Collins SI, Young LS (2007). The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer, 7: 11-22. doi:10.1038/nrc2050 PMID:17186016
397. Woodworth CD, Doniger J, DiPaolo JA (1989). Immortalization of human foreskin keratinocytes by various human papillomavirus DNAs corresponds to their association with cervical carcinoma. J Virol, 63: 159-164. PMID:2462058
398. Wu EQ, Zhang GN, Yu XH et al. (2008). Evaluation of high-risk human papillomaviruses type distribution in cervical cancer in Sichuan province of China. BMC Cancer, 8: 202 doi:10.1186/1471-2407-8-202 PMID:18644159
399. Wu Y, Chen Y, Li L et al. (2006). Associations of high-risk HPV types and viral load with cervical cancer in China. J Clin Virol, 35: 264-269. doi:10.1016/j.jcv.2005.07.011 PMID:16183329
400. Yan M, Peng J, Jabbar IA et al. (2005). Activation of dendritic cells by human papillomavirus-like particles through TLR4 and NF-kappaB-mediated signalling, moderated by TGF-beta. Immunol Cell Biol, 83: 83-91. doi:10.1111/j.1440-1711.2004.01291.x PMID:15661045
401. Yang R, Murillo FM, Cui H et al. (2004). Papillomaviruslike particles stimulate murine bone marrowderived dendritic cells to produce alpha interferon and Th1 immune responses via MyD88. J Virol, 78: 11152-11160. doi:10.1128/JVI.78.20.11152-11160.2004 PMID:15452235
402. Yasumoto S, Burkhardt AL, Doniger J, DiPaolo JA (1986). Human papillomavirus type 16 DNA-induced malignant transformation of NIH 3T3 cells. J Virol, 57: 572-577. PMID:3003388
403. Ylitalo N, Sørensen P, Josefsson A et al. (1999). Smoking and oral contraceptives as risk factors for cervical carcinoma in situ. Int J Cancer, 81: 357-365. doi:10.1002/(SICI)1097-0215(19990505)81:3<357::AIDIJC8>3.0.CO;2-1 PMID:10209949
404. Yoshinouchi M, Yamada T, Kizaki M et al. (2003). In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by E6 siRNA. Mol Ther, 8: 762-768. doi:10.1016/j.ymthe.2003.08.004 PMID:14599809
405. Zelmanowicz AdeM, Schiffman M, Herrero R et al. (2005). Family history as a co-factor for adenocarcinoma and squamous cell carcinoma of the uterine cervix: results from two studies conducted in Costa Rica and the United States. Int J Cancer, 116: 599-605. doi:10.1002/ijc.21048 PMID:15818615
406. Zhang B, Li P, Wang E et al. (2003). The E5 protein of human papillomavirus type 16 perturbs MHC class II antigen maturation in human foreskin keratinocytes treated with interferon-gamma. Virology, 310: 100-108. doi:10.1016/S0042-6822(03)00103-X PMID:12788634
407. Zhao Y, Lin H, Shen D et al. (2008). Distribution of HPV genotypes in uterine cervical lesions in Yanbian, northern China. Pathol Int, 58: 643-647. doi:10.1111/j.1440-1827.2008.02283.x PMID:18801084
408. Zuna RE, Allen RA, Moore WE et al. (2007). Distribution of HPV genotypes in 282 women with cervical lesions: evidence for three categories of intraepithelial lesions based on morphology and HPV type. Mod Pathol, 20: 167-174. doi:10.1038/modpathol.3800723 PMID:17192793